Key points are not available for this paper at this time.
VD may be an antifibrotic treatment option early in the onset of fibrosis in specific genotypes for VDR. Known polymorphisms of the VDR may influence the response to VD treatment.
Beilfuss et al. (Mon,) studied this question.